Skip to main content
Matthew Crowley, MD, Endocrinology, Durham, NC

MatthewJanikCrowleyMD

Endocrinology Durham, NC

Diabetes, Lipid Metabolism

Associate Professor of Medicine, Duke University School of Medicine

Dr. Crowley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Crowley's full profile

Already have an account?

  • Office

    2301 Erwin Rd
    Durham, NC 27705
    Phone+1 919-684-8111

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2011
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2004 - 2007
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 2004

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2004 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Impact of Metformin Use on the Cardiovascular Effects of DPP‐4 Inhibitors: An Analysis of Medicare Claims Data 2007‐2015  
    John B Buse, Matthew J Crowley, Virginia Pate, Diabetes, Obesity and Metabolism
  • Revisiting NPH Insulin for Type 2 DiabetesIs a Step Back the Path Forward?  
    Matthew Crowley, MD, JAMA

Lectures

  • Use of Metformin in Patients with Historical Contraindications and Precautions 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018

Press Mentions

  • Comprehensive Telehealth Intervention Improves Outcomes for People with Type 2 Diabetes
    Comprehensive Telehealth Intervention Improves Outcomes for People with Type 2 DiabetesAugust 4th, 2022
  • Comprehensive Telehealth Boosts Outcomes in Poorly Controlled Diabetes
    Comprehensive Telehealth Boosts Outcomes in Poorly Controlled DiabetesJuly 25th, 2022
  • Basal Insulin Doesn't Cut Hypoglycemia Risk vs NPH in T2D
    Basal Insulin Doesn't Cut Hypoglycemia Risk vs NPH in T2DJune 24th, 2018

Professional Memberships